BARCELONA, Spain , May 22, 2017 /PRNewswire/ — Anaconda Biomed, a pre-clinical stage medical device company focused on the development of the next generation of neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announces it has closed a Series A financing…
No comments:
Post a Comment